Few Disparities in Baseline Laboratory Testing After the Diuretic or Digoxin Initiation by Medicare Fee-For-Service Beneficiaries

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Circulation. Cardiovascular Quality and Outcomes

• Publication date

  2016-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCOUTCOMES.116.003052PMID 27756796PMCID PMC5339025
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Linkage of Laboratory Results to Medicare Fee-for-Service Claims

  2015cited by this paper
• Emergency Department Visits and Hospitalizations for Digoxin Toxicity: United States, 2005 to 2010

  2014cited by this paper
• Guideline Concordance of Testing for Hyperkalemia and Kidney Dysfunction During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure

  2014cited by this paper
• Racial and ethnic disparities among enrollees in Medicare Advantage plans.

  2014cited by this paper
• Digoxin initiation is associated with lower risk of all-cause readmission after hospitalisation for heart failure

  2014cited by this paper
• How to achieve health equity.

  2014cited by this paper
• Racial/Ethnic Differences in Medicare Experiences and Immunization: The Role of Disease Burden

  2013cited by this paper
• A Roadmap and Best Practices for Organizations to Reduce Racial and Ethnic Disparities in Health Care

  2012cited by this paper
• Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments

  2012cited by this paper
• Ethnic Disparities in Adherence to Antihypertensive Medications of Medicare Part D Beneficiaries

  2012cited by this paper
• Beyond the Prescription: Medication Monitoring and Adverse Drug Events in Older Adults

  2011cited by this paper
• Chronic Care: Making the Case for Ongoing Care

  2010cited by this paper
• Frequency of failure to inform patients of clinically significant outpatient test results.

  2009cited by this paper
• More Accurate Racial and Ethnic Codes for Medicare Administrative Data

  2008cited by this paper
• National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents.

  2008cited by this paper
• Interventions to Reduce Racial and Ethnic Disparities in Health Care

  2007cited by this paper
• Cultural Leverage

  2007cited by this paper
• Barriers to Self-Management and Quality-of-Life Outcomes in Seniors With Multimorbidities

  2007cited by this paper
• Relationship between number of medical conditions and quality of care.

  2007cited by this paper
• National surveillance of emergency department visits for outpatient adverse drug events.

  2006cited by this paper
• Improved therapeutic monitoring with several interventions: a randomized trial.

  2006cited by this paper
• Baseline Laboratory Monitoring of Cardiovascular Medications in Elderly Health Maintenance Organization Enrollees

  2005cited by this paper
• Comorbidity and the Use of Primary Care and Specialist Care in the Elderly

  2005cited by this paper
• Laboratory monitoring of drugs at initiation of therapy in ambulatory care

  2005cited by this paper
• Linking laboratory and pharmacy: opportunities for reducing errors and improving care.

  2003cited by this paper
• Prevalence, expenditures, and complications of multiple chronic conditions in the elderly.

  2002cited by this paper

• Differences in Arterial Blood Gas Testing by Race and Sex Across 161 US Hospitals in 4 EHR Databases.

  2025cites this paper
• Frequency of Clinical Monitoring of Serum Concentrations of Digoxin, Potassium, and Creatinine, and Recording of Electrocardiograms in Digoxin-Treated Patients: A Japanese Claims Database Analysis.

  2020cites this paper